Title of SMI goes here

These are resistant to cefpodoxime, aztreonam and piperacillin-tazobactam, but not ceftazidime5. They may give weak positive clavulanate synergy tests with cefotaxime or cefepime (not ceftazidime), leading to confusion with ESBL producers41. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download